1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate, 06:0 Lyso PA

Product Description

1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate, 06:0 Lyso PA
Catalog number: B2019005
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 5 mg
Molecular Weight or Concentration: 287 g/mol
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: 06:0 Lyso PA, 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), PA(6:0/0:0)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Lin WL, Chien MM, Patchara S, Wang W, Faradina A, Huang SY, Tung TH, Tsai CS, Skalny AV, Tinkov AA, Chang CC, Chang JS. Essential trace element and phosphatidylcholine remodeling: Implications for body composition and insulin resistance J Trace Elem Med Biol. 2024 Sep;85:127479.
2: Greiner CA, Greiner JV, Hebert E, Berthiaume RR, Glonek T. Phospholipid analysis of mammalian optic nerve tissue: a 31P nuclear magnetic resonance spectroscopic study Ophthalmic Res. 1994;26(5):264-74.
3: Surti S, Zou W, Daube-Witherspoon ME, McDonough J, Karp JS. Design study of an in situ PET scanner for use in proton beam therapy Phys Med Biol. 2011 May 7;56(9):2667-85.
4: Anjani K, Lhomme M, Sokolovska N, Poitou C, Aron-Wisnewsky J, Bouillot JL, Lesnik P, Bedossa P, Kontush A, Clement K, Dugail I, Tordjman J. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity J Hepatol. 2015 Apr;62(4):905-12.
5: Scheffer PG, Henry RM, Wever EJ, van Rooij GJ, Bos G, Heine RJ, Dekker JM, Diamant M, Stehouwer CD, Nijpels G, Blankenstein MA, Teerlink T. LDL oxidative modifications in well- or moderately controlled type 2 diabetes Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):298-304.
6: van der Vusse GJ, de Groot MJ, Willemsen PH, van Bilsen M, Schrijvers AH, Reneman RS. Degradation of phospholipids and triacylglycerol, and accumulation of fatty acids in anoxic myocardial tissue, disrupted by freeze-thawing Mol Cell Biochem. 1989 Jun 27-Jul 24;88(1-2):83-90.
7: Gorrochategui E, Pérez-Albaladejo E, Casas J, Lacorte S, Porte C. Perfluorinated chemicals: differential toxicity, inhibition of aromatase activity and alteration of cellular lipids in human placental cells Toxicol Appl Pharmacol. 2014 Jun 1;277(2):124-30.
8: Nathan N, Denizot Y, Feiss P, Laskar M, Arnoux B, Benveniste J. Variations of blood PAF-acether levels during coronary artery surgery J Cardiothorac Vasc Anesth. 1992 Dec;6(6):692-6.
9: McHowat J, Kell PJ, O’Neill HB, Creer MH. Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2) Biochemistry. 2001 Dec 11;40(49):14921-31.
10: Kunievsky B, Yavin E. Production and metabolism of platelet-activating factor in the normal and ischemic fetal rat brain J Neurochem. 1994 Dec;63(6):2144-51.

Products Related to 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate, 06:0 Lyso PA can be found at Lipids